Leukemia & Lymphoma, Volume 61, Issue 11 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 61, Issue 11 (2020)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Volume 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Follicular lymphoma – a better understanding to transform outcomes?
Clémentine Sarkozy & David W. Scott
Pages: 2539-2541
Published online: 30 Jul 2020
First Page PreviewforFollicular lymphoma – a better understanding to transform outcomes? | Full Text | References | PDF (323 KB) | EPUB
  • 189 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Event free survival at 12 months (EFS12) in stage 1 DLBCL – a reassuring milestone?
Katharine L. Lewis & Chan Yoon Cheah
Pages: 2542-2543
Published online: 19 Aug 2020
CitationforEvent free survival at 12 months (EFS12) in stage 1 DLBCL – a reassuring milestone? | Full Text | References | PDF (245.3 KB) | EPUB
  • 49 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Toward a cure in relapsed ALL: we must do better
Partow Kebriaei
Pages: 2544-2545
Published online: 11 Aug 2020
CitationforToward a cure in relapsed ALL: we must do better | Full Text | References | PDF (252.1 KB) | EPUB
  • 74 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Improving end-of-life care for patients with leukemia: is inpatient death the right measure?
Thomas W. LeBlanc
Pages: 2546-2548
Published online: 29 Oct 2020
First Page PreviewforImproving end-of-life care for patients with leukemia: is inpatient death the right measure? | Full Text | References | PDF (415.2 KB) | EPUB
  • 159 Views
  • 2 CrossRef citations
  • 0Altmetric

Reviews

Management of newly diagnosed transplant ineligible multiple myeloma
Shebli Atrash, Manisha Bhutani, Barry Paul, Peter M. Voorhees & Saad Z. Usmani
Pages: 2549-2560
Published online: 04 Jul 2020
AbstractforManagement of newly diagnosed transplant ineligible multiple myeloma | Full Text | References | PDF (1.6 MB) | EPUB
  • 438 Views
  • 1 CrossRef citations
  • 0Altmetric
Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomas
P. Connor Johnson & Jeremy S. Abramson
Pages: 2561-2567
Published online: 01 Jul 2020
AbstractforPatient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomas | Full Text | References | PDF (663.6 KB) | EPUB
  • 1040 Views
  • 15 CrossRef citations
  • 0Altmetric

Original Articles

Article
Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience
Vincent Pillonel, Darius Juskevicius, Michel Bihl, Frank Stenner, Jörg P. Halter, Stefan Dirnhofer & Alexandar Tzankov
Pages: 2568-2583
Published online: 04 Jul 2020
AbstractforRoutine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 602 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort
Charlotte Madsen, Trine Lindhardt Plesner, Hans Herluf Bentzen, Judit Jørgensen, Ida Blok Sillesen, Bodil M. Himmelstrup, Pär Josefsson, Torben Plesner, Tine Litske Bennedsen, Maja Ludvigsen & Francesco A. d’Amore
Pages: 2584-2594
Published online: 17 Jun 2020
AbstractforReal world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort | Full Text | References | PDF (1.3 MB) | EPUB
  • 439 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphoma
Susanne Bram Ednersson, Mimmie Stern, Henrik Fagman, Herman Nilsson-Ehle, Sverker Hasselblom & Per-Ola Andersson
Pages: 2595-2604
Published online: 16 Jun 2020
AbstractforTBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphoma | Full Text | References | PDF (2.8 MB) | EPUB | Supplemental
  • 1406 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
High incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma
Anjlee Mahajan, Ann Brunson, Theresa H. M. Keegan, Aaron Rosenberg & Ted Wun
Pages: 2605-2613
Published online: 23 Jun 2020
AbstractforHigh incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 324 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group
Kitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, Arnuparp Lekhakula, Supachai Ekwattanakit, Archrob Khuhapinant, Pimjai Niparuck, Suporn Chuncharunee, Tontanai Numbenjapon, Kannadit Prayongratana, Nonglak Kanitsap, Somchai Wongkhantee, Nisa Makruasi, Peerapon Wong, Lalita Norasetthada, Weerasak Nawarawong, Chittima Sirijerachai, Kanchana Chansung, Tawatchai Suwanban, Pannee Praditsuktavorn, Tanin Intragumtornchai & on behalf of Thai Lymphoma Study Group
Pages: 2614-2621
Published online: 23 Jun 2020
AbstractforEvent-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group | Full Text | References | PDF (812.3 KB) | EPUB | Supplemental
  • 259 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma
Jason N. Barreto, Carrie A. Thompson, Patrick M. Wieruszewski, Amanda G. Pawlenty, Kristin C. Mara, Ashley L. Potter, Pritish K. Tosh & Andrew H. Limper
Pages: 2622-2629
Published online: 05 Jul 2020
AbstractforIncidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma | Full Text | References | PDF (1.5 MB) | EPUB
  • 307 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Patient preferences for first-line treatment of classical Hodgkin lymphoma: a US survey and discrete choice experiment
Niloufer Khan, Joseph Feliciano, Kerstin Müller, Mary He, Rei Tao, Ellen Korol, Mehul Dalal, Mayvis Rebeira & Matthew Matasar
Pages: 2630-2637
Published online: 20 Jul 2020
AbstractforPatient preferences for first-line treatment of classical Hodgkin lymphoma: a US survey and discrete choice experiment | Full Text | References | PDF (798.8 KB) | EPUB | Supplemental
  • 263 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Rituximab is not associated with increased risk of second primary malignancies in Israeli patients with diffuse large B cell lymphoma treated with RCHOP regimen
Yuval Neeman, Chava Perry, Barbara Silverman, Nizan Waintraub & Irit Avivi
Pages: 2638-2644
Published online: 01 Jul 2020
AbstractforRituximab is not associated with increased risk of second primary malignancies in Israeli patients with diffuse large B cell lymphoma treated with RCHOP regimen | Full Text | References | PDF (811.8 KB) | EPUB | Supplemental
  • 174 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Progression of disease within 24 months of initial therapy (POD24) detected incidentally in imaging does not necessarily indicate worse outcome
Guy Bitansky, Abraham Avigdor, Elena Vasilev, Maya Zlotnick, Elena Ribakovsky, Ohad Benjamini, Arnon Nagler & Meirav Kedmi
Pages: 2645-2651
Published online: 09 Jul 2020
AbstractforProgression of disease within 24 months of initial therapy (POD24) detected incidentally in imaging does not necessarily indicate worse outcome | Full Text | References | PDF (804.6 KB) | EPUB
  • 208 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)
Pamela B. Allen, Jeffrey Switchenko, Amy Ayers, Esther Kim & Mary Jo Lechowicz
Pages: 2652-2658
Published online: 19 Jun 2020
AbstractforRisk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL) | Full Text | References | PDF (759.1 KB) | EPUB
  • 245 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
The predictive value of pre-treatment 18F-FDG PET/CT on treatment outcome in early-stage extranodal natural killer/T-cell lymphoma
Rui Guo, Pengpeng Xu, Haoping Xu, Ying Miao & Biao Li
Pages: 2659-2664
Published online: 23 Jun 2020
AbstractforThe predictive value of pre-treatment 18F-FDG PET/CT on treatment outcome in early-stage extranodal natural killer/T-cell lymphoma | Full Text | References | PDF (646.8 KB) | EPUB
  • 201 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
Nicola Gökbuget, Gerhard Zugmaier, Hervé Dombret, Anthony Stein, Massimiliano Bonifacio, Carlos Graux, Christoph Faul, Monika Brüggemann, Kate Taylor, Noemi Mergen, Albrecht Reichle, Heinz-August Horst, Violaine Havelange, Max S. Topp & Ralf C. Bargou
Pages: 2665-2673
Published online: 03 Jul 2020
AbstractforCurative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 9836 Views
  • 34 CrossRef citations
  • 0Altmetric
Open Access
Article
Acute lymphoblastic leukemia mortality in Hispanic Americans
Jamie M. Shoag, Julio C. Barredo, Izidore S. Lossos & Paulo S. Pinheiro
Pages: 2674-2681
Published online: 22 Jun 2020
AbstractforAcute lymphoblastic leukemia mortality in Hispanic Americans | Full Text | References | PDF (631.1 KB) | EPUB
  • 477 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
The prognostic value of plasma fibrinogen level in patients with acute myeloid leukemia: a systematic review and meta-analysis
Ziyan Zhang, Rui Zhang, Jiaqian Qi, Wenjing Miao, Kun Fang, Changgeng Ruan, Depei Wu & Yue Han
Pages: 2682-2691
Published online: 01 Jul 2020
AbstractforThe prognostic value of plasma fibrinogen level in patients with acute myeloid leukemia: a systematic review and meta-analysis | Full Text | References | PDF (1.2 MB) | EPUB
  • 192 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD
Cong Liang, Chun-Jin Peng, Li-Na Wang, Yu Li, Li-Min Zheng, Zhong Fan, Dan-Ping Huang, Wen-Yan Tang, Xiao-Li Zhang, Li-Bin Huang, Yan-Lai Tang & Xue-Qun Luo
Pages: 2692-2699
Published online: 14 Jun 2020
AbstractforArsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD | Full Text | References | PDF (2.1 MB) | EPUB
  • 281 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience
Armon Azizi, Asiri Ediriwickrema, Ritika Dutta, Shyam A. Patel, William Shomali, Bruno Medeiros, David Iberri, Jason Gotlib, Gabriel Mannis, Peter Greenberg, Ravindra Majeti & Tian Zhang
Pages: 2700-2707
Published online: 16 Jun 2020
AbstractforVenetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 1550 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Early detection of infectious complications during induction therapy for acute leukemia with serial C-reactive protein biomarker assessment
Shai Shimony, Uri Rozovski, Neta Sudry, Moshe Yeshurun, Dafna Yahav, Pia Raanani & Ofir Wolach
Pages: 2708-2713
Published online: 24 Jun 2020
AbstractforEarly detection of infectious complications during induction therapy for acute leukemia with serial C-reactive protein biomarker assessment | Full Text | References | PDF (716.5 KB) | EPUB | Supplemental
  • 142 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis
Ga-Young Song, Sung-Hoon Jung, Je-Jung Lee, Jin Seok Kim, Chang-Ki Min, Kihyun Kim, Yunsuk Choi, Hyeon-Seok Eom, Young Don Joo, Sung-Hyun Kim, Jae-Yong Kwak, Hye Jin Kang, Jae Hoon Lee, Ho Sup Lee, Yeung-Chul Mun, Joon Ho Moon, Sang Kyun Sohn, Seong Kyu Park, Yong Park, Ho-Jin Shin & Sung-Soo Yoon
Pages: 2714-2721
Published online: 25 Jun 2020
AbstractforIntravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis | Full Text | References | PDF (889.8 KB) | EPUB
  • 372 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Short-term treatment with imetelstat sensitizes hematopoietic malignant cells to a genotoxic agent via suppression of the telomerase-mediated DNA repair process
Daisuke Hidaka, Masahiro Onozawa, Naohiro Miyashita, Shota Yokoyama, Masao Nakagawa, Daigo Hashimoto & Takanori Teshima
Pages: 2722-2732
Published online: 22 Jun 2020
AbstractforShort-term treatment with imetelstat sensitizes hematopoietic malignant cells to a genotoxic agent via suppression of the telomerase-mediated DNA repair process | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 137 Views
  • 4 CrossRef citations
  • 0Altmetric

Letters to the Editor

Low-dose vemurafenib monotherapy in BRAFV600E-mutated Erdheim-Chester disease
Gordon J. Ruan, Antonious Hazim, Jithma P. Abeykoon, Caleb Scheckel, Robert Vassallo, Jay H. Ryu, W. Oliver Tobin, Matthew J. Koster, N. Nora Bennani, Karen L. Rech, Jason R. Young, Mithun V. Shah, Gaurav Goyal, Ronald S. Go & On behalf of the Mayo Clinic Histiocytosis Working Group
Pages: 2733-2737
Published online: 01 Jul 2020
First Page PreviewforLow-dose vemurafenib monotherapy in BRAFV600E-mutated Erdheim-Chester disease | Full Text | References | PDF (899.2 KB) | EPUB | Supplemental
  • 329 Views
  • 8 CrossRef citations
  • 0Altmetric
Identifying an obinutuzumab resistant subpopulation of monocyte-derived-macrophages from patients with CLL
Melinda Burgess, Yu Chen Enya Chen, Sally Mapp, Peter Mollee, Devinder Gill & Nicholas A. Saunders
Pages: 2738-2742
Published online: 14 Jun 2020
First Page PreviewforIdentifying an obinutuzumab resistant subpopulation of monocyte-derived-macrophages from patients with CLL | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 166 Views
  • 2 CrossRef citations
  • 0Altmetric
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of Baltimore
Andrew Y. Li, Sarah M. Kashanian, Bryan C. Hambley, Kyle Zacholski, Maria R. Baer, Vu H. Duong, Firas El Chaer, Noa G. Holtzman, Kelly J. Norsworthy, Mark J. Levis, B. Douglas Smith, Farin Kamangar, Gabriel Ghiaur & Ashkan Emadi
Pages: 2743-2747
Published online: 14 Jun 2020
First Page PreviewforClustered incidence of adult acute promyelocytic leukemia in the vicinity of Baltimore | Full Text | References | PDF (742.3 KB) | EPUB
  • 175 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Haploidentical hematopoietic stem cell transplantation with ‘Beijing protocol’ in the treatment of T-lymphoblastic lymphoma
Jia-Pei Lu, Fu-Xu Wang, Shu-Peng Wen, Xuan Liu, Ying Wang, Zhi-Yun Niu & Xue-Jun Zhang
Pages: 2748-2751
Published online: 16 Jun 2020
First Page PreviewforHaploidentical hematopoietic stem cell transplantation with ‘Beijing protocol’ in the treatment of T-lymphoblastic lymphoma | Full Text | References | PDF (1.2 MB) | EPUB
  • 115 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study
M. Cruijsen, W.J.F.M van der Velden, A.F.J. de Haan, S. K. Klein, M. Hoogendoorn, Y. Tromp, B. de Valk, B. van Rees, F. de Boer, E. van der Spek, J. Pruijt, L.F. Verdonck, E. Vellenga, N. Blijlevens, A. A. van de Loosdrecht & G. Huls
Pages: 2752-2755
Published online: 12 Jun 2020
First Page PreviewforUse of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study | Full Text | References | PDF (746.8 KB) | EPUB | Supplemental
  • 162 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Venetoclax induced complete remission in extramedullary relapse of AML co-harboring NPM1, TET2, and NRAS mutations after haploidentical hematopoietic stem cell transplantation
Wenjue Pan, Xiujie Zhao, Wei Shi, Zhinong Jiang & Haowen Xiao
Pages: 2756-2759
Published online: 17 Jun 2020
First Page PreviewforVenetoclax induced complete remission in extramedullary relapse of AML co-harboring NPM1, TET2, and NRAS mutations after haploidentical hematopoietic stem cell transplantation | Full Text | References | PDF (658.6 KB) | EPUB
  • 372 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Patients with leukemia dying in the hospital: results of the national inpatient sample and a call to do better
Ghulam Rehman Mohyuddin, Saqib Abbasi, Jacob Ripp, Anurag Singh, Suman Kambhampati & Brian McClune
Pages: 2760-2762
Published online: 18 Jun 2020
First Page PreviewforPatients with leukemia dying in the hospital: results of the national inpatient sample and a call to do better | Full Text | References | PDF (300.4 KB) | EPUB
  • 112 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
SARS-CoV-2 in multiple myeloma: initial observation and management
Elisabet E. Manasanch, Victor Mulanovich, Joanna-Grace Manzano, Maria Susan Gaeta, Melody Becnel, Gregory P. Kaufman, Hans C. Lee, Behrang Amini, Sheeba K. Thomas, Swaminathan P. Iyer, Donna M. Weber, Zuzana Berkova, Christopher R. Flowers, Robert Z. Orlowski & Krina K. Patel
Pages: 2763-2766
Published online: 17 Jun 2020
First Page PreviewforSARS-CoV-2 in multiple myeloma: initial observation and management | Full Text | References | PDF (430.5 KB) | EPUB
  • 996 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma
Andreas Viardot, Georg Hess, Ralf C. Bargou, Nicholas J. Morley, Giuseppe Gritti, Maria-Elisabeth Goebeler, Karim Iskander, David Cohan, Alicia Zhang, Janet Franklin & Luke Coyle
Pages: 2767-2770
Published online: 07 Jul 2020
First Page PreviewforDurability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma | Full Text | References | PDF (735.6 KB) | EPUB | Supplemental
  • 2089 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Letter
Hispanic ethnicity is associated with prolonged clearance of high dose methotrexate and severe nephrotoxicity in children and adolescents with acute lymphoblastic leukemia
Dolores Mullikin, Daniel Ranch, Yasmin Khalfe, Brandon Lucari, Mark C. Zobeck, Chatchawin Assanasen, M. Monica Gramatges, Michael E. Scheurer & Eric S. Schafer
Pages: 2771-2774
Published online: 01 Jul 2020
First Page PreviewforHispanic ethnicity is associated with prolonged clearance of high dose methotrexate and severe nephrotoxicity in children and adolescents with acute lymphoblastic leukemia | Full Text | References | PDF (773.3 KB) | EPUB | Supplemental
  • 248 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Nelarabine-related rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia
Ramesh Kumar Pandey, Adam DiPippo, Tapan Kadia, Naveen Pemmaraju, Biruh Tesfa Workeneh, Elias Jabbour, Farhad Ravandi & Nitin Jain
Pages: 2775-2777
Published online: 11 Jul 2020
First Page PreviewforNelarabine-related rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia | Full Text | References | PDF (480.5 KB) | EPUB
  • 219 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Effects of ibrutinib on glucose-lipid metabolism in patients with chronic lymphocytic leukemia (CLL)
Stefano Molica, Mirella Lentini, Daniela Zappalà & Luciano Levato
Pages: 2778-2780
Published online: 16 Jun 2020
First Page PreviewforEffects of ibrutinib on glucose-lipid metabolism in patients with chronic lymphocytic leukemia (CLL) | Full Text | References | PDF (484 KB) | EPUB
  • 224 Views
  • 3 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Page: 2781
Published online: 19 Oct 2020
CitationforCorrection | Full Text | PDF (93 KB) | EPUB
  • 497 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles